Literature DB >> 8941450

Joint hypermobility syndromes.

M L Raff1, P H Byers.   

Abstract

Inherited connective tissue disorders, among them Ehlers-Danlos syndrome, osteogenesis imperfecta, Marfan syndrome, and Larsen syndrome, are characterized by generalized joint hypermobility. Others, such as Morquio syndrome or achondroplasia, have hypermobility in a more limited distribution. Recent clinical and molecular genetic studies have defined the range of clinical variation and the underlying molecular defects in several disorders. These studies provide hope that more common varieties of joint hypermobility can be understood and that effective therapies are within reach.

Entities:  

Mesh:

Year:  1996        PMID: 8941450     DOI: 10.1097/00002281-199609000-00012

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  4 in total

1.  Joint laxity in the parents of children with temporary brittle bone disease.

Authors:  Colin R Paterson; Patricia A Mole
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

2.  Lumican deficiency results in cardiomyocyte hypertrophy with altered collagen assembly.

Authors:  Loren E Dupuis; Matthew G Berger; Samuel Feldman; Lorna Doucette; Vennece Fowlkes; Shukti Chakravarti; Sarah Thibaudeau; Nicolas E Alcala; Amy D Bradshaw; Christine B Kern
Journal:  J Mol Cell Cardiol       Date:  2015-04-15       Impact factor: 5.000

3.  Neonatal familial Evans syndrome associated with joint hypermobility and mitral valve regurgitation in three siblings in a Saudi Arab family.

Authors:  Fathelrahman E Ahmed; Mohameed S Albakrah
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

4.  Total Joint Arthroplasty in Patients With Achondroplasia: Comparison of 90-Day Adverse Events and 5-Year Implant Survival.

Authors:  Harold G Moore; Christopher A Schneble; Joseph B Kahan; Gregory G Polkowski; Lee E Rubin; Jonathan N Grauer
Journal:  Arthroplast Today       Date:  2021-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.